ArticleHuman vaccines & immunotherapeutics2024

Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy.

Yunyi Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.